April 29, 2013
Bernstein Liebhard LLP is investigating whether the Board of Directors of Conceptus, Inc. (“Conceptus” or the “Company”) (NASDAQ: CPTS) breached its fiduciary duty to its shareholders in agreeing to sell Conceptus to Bayer HealthCare LLC.
Under the terms of the agreement, Conceptus shareholders will receive $31.00 in cash for each share they own. The investigation is focused on the potential unfairness of the price to Conceptus shareholders and the process by which the Conceptus Board of Directors considered and approved the transaction.
Bernstein Liebhard LLP has pursued hundreds of securities, consumer and shareholder rights cases and recovered over $3 billion for its clients. It has been named to The National Law Journal’s “Plaintiffs’ Hot List” in each of the last ten years.